29.77
-0.20
(-0.67%)
At close: January 24 at 8:01:11 AM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 8 | 6 | 10 | 10 |
Avg. Estimate | 279.19M | 278.94M | 1.09B | 1.16B |
Low Estimate | 278.39M | 276.26M | 1.09B | 1.14B |
High Estimate | 281.28M | 281.9M | 1.09B | 1.18B |
Year Ago Sales | 262.88M | 264.66M | 1.04B | 1.09B |
Sales Growth (year/est) | 6.21% | 5.40% | 5.02% | 6.35% |
EPS Trend
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 2025) | Next Qtr. (Apr 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
3BX.F | -- | -- | -- | -- |
S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
Initiated | DA Davidson: Buy | 12/18/2024 |
Initiated | B of A Securities: Buy | 12/12/2024 |
Reiterates | RBC Capital: Underperform to Underperform | 12/4/2024 |
Maintains | Citigroup: Buy to Buy | 12/4/2024 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/4/2024 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 9/5/2024 |